Whitehawk Therapeutics Inc. (NASDAQ:WHWK ) Q4 2024 Results Conference Call March 19, 2025 8:30 AM ET Company Participants Audrey Gross - Head of Corporate Communications Dave Lennon - President and Chief Executive Officer Scott Giacobello - Chief Financial Officer, Investor Relations and Corporate Communications David Dornan - Chief Scientific Officer Conference Call Participants Greg Weasner - TD Securities Liang Cheng - Jefferies Operator Ladies and gentlemen, thank you for standing by. Welcome to Whitehawk Therapeutics Fourth Quarter and Full Year 2024 Earnings Call.